Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 427

1.

Use of population modeling to define rational monitoring of amiodarone hepatic effects.

Pollak PT, Shafer SL.

Clin Pharmacol Ther. 2004 Apr;75(4):342-51.

PMID:
15060512
[PubMed - indexed for MEDLINE]
2.

Prevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction.

Kum LC, Chan WW, Hui HH, Wong GW, Ho SS, Sanderson JE, Yu CM, Fung JW.

Clin Cardiol. 2006 Jul;29(7):295-9.

PMID:
16881537
[PubMed - indexed for MEDLINE]
3.

Population pharmacokinetics of long-term oral amiodarone therapy.

Pollak PT, Bouillon T, Shafer SL.

Clin Pharmacol Ther. 2000 Jun;67(6):642-52.

PMID:
10872646
[PubMed - indexed for MEDLINE]
4.

Causality assessment of liver injury after chronic oral amiodarone intake.

Llanos L, Moreu R, Peiró AM, Pascual S, Francés R, Such J, Horga JF, Pérez-Mateo M, Zapater P.

Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):291-300. doi: 10.1002/pds.1709.

PMID:
19165760
[PubMed - indexed for MEDLINE]
5.

Evaluation of a pharmacist-managed amiodarone monitoring program.

Spence MM, Polzin JK, Weisberger CL, Martin JP, Rho JP, Willick GH.

J Manag Care Pharm. 2011 Sep;17(7):513-22.

PMID:
21870892
[PubMed - indexed for MEDLINE]
Free Article
6.

Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure.

Mattar W, Juliar B, Gradus-Pizlo I, Kwo PY.

J Gastrointestin Liver Dis. 2009 Dec;18(4):419-23.

PMID:
20076813
[PubMed - indexed for MEDLINE]
Free Article
7.

Clinical applications and acute hepatotoxicity of intravenous amiodarone.

Huang X, Yang Y, Zhu J, Gao X, Wang G, Tan H, Liang Y, Li J.

J Int Med Res. 2009 Nov-Dec;37(6):1928-36.

PMID:
20146893
[PubMed - indexed for MEDLINE]
8.

Rapid acute amiodarone-induced hepatotoxicity in a burn patient.

Maker AV, Orgill DP.

J Burn Care Rehabil. 2005 Jul-Aug;26(4):341-3.

PMID:
16006841
[PubMed - indexed for MEDLINE]
9.

Amiodarone hepatotoxicity.

Babatin M, Lee SS, Pollak PT.

Curr Vasc Pharmacol. 2008 Jul;6(3):228-36. Review.

PMID:
18673162
[PubMed - indexed for MEDLINE]
10.

Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.

Watkins PB, Dube LM, Walton-Bowen K, Cameron CM, Kasten LE.

Drug Saf. 2007;30(9):805-15.

PMID:
17722971
[PubMed - indexed for MEDLINE]
11.

Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration.

Kotake T, Takada M, Goto T, Komamura K, Kamakura S, Morishita H.

J Clin Pharm Ther. 2006 Jun;31(3):237-43.

PMID:
16789989
[PubMed - indexed for MEDLINE]
12.
13.

Monitoring of hepatic function during amiodarone therapy.

Pollak PT, You YD.

Am J Cardiol. 2003 Mar 1;91(5):613-6. No abstract available.

PMID:
12615276
[PubMed - indexed for MEDLINE]
14.

Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients.

Iervasi G, Clerico A, Manfredi C, Sabatino L, Biagini A, Chopra IJ.

Clin Endocrinol (Oxf). 1997 Dec;47(6):699-705.

PMID:
9497877
[PubMed - indexed for MEDLINE]
15.

[Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].

González Galilea A, García Sánchez MV, la Mata García M, Miño Fugarolas G.

Gastroenterol Hepatol. 2002 Jun-Jul;25(6):392-4. Spanish.

PMID:
12069701
[PubMed - indexed for MEDLINE]
16.

[Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].

Jmelnitzky AC, Guidi M, Bologna A, Viola M, Soccini C, Barbero R, Belloni P, Apraiz M.

Acta Gastroenterol Latinoam. 2000;30(2):77-84. Spanish.

PMID:
10925723
[PubMed - indexed for MEDLINE]
17.

Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.

Shakya R, Rao BS, Shrestha B.

Ann Pharmacother. 2004 Jun;38(6):1074-9. Epub 2004 Apr 30.

PMID:
15122004
[PubMed - indexed for MEDLINE]
18.

Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment.

Fetterly GJ, Owen JS, Stuyckens K, Passarell JA, Zannikos P, Soto-Matos A, Izquierdo MA, Perez-Ruixo JJ.

Cancer Chemother Pharmacol. 2008 Jun;62(1):135-47. Epub 2007 Oct 9.

PMID:
17922277
[PubMed - indexed for MEDLINE]
19.

Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients.

Araki R, Yukawa E, Nakashima MN, Fukuchi H, Sasaki H, Yano K, Nakashima M.

Ther Drug Monit. 2011 Dec;33(6):750-6. doi: 10.1097/FTD.0b013e318239a728.

PMID:
22105593
[PubMed - indexed for MEDLINE]
20.

Optimizing oral dosing and monitoring of noncardiac toxicities with chronic amiodarone therapy.

Tsikouris JP, White CM, Kluger J.

Conn Med. 2000 Jan;64(1):35-8. Review. No abstract available.

PMID:
10697362
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk